Sunday, December 11, 2016 5:08:59 PM
I speak from experience -- experience that is easy to duplicate.
My advice -- don't take my word for it or blindly listen to some other dude down 80% on his stock.
Three options:
1. Walk into a competent brokerage house with that plan printed out. Be prepared to hear them chuckle but they will be nice.
2. Do the same thing only with any college professor in the finance department.
3. Do some googling and see for yourself how this stuff works. See if exactly what I said it was happens every time or see if I'm wrong and there are counter examples. The closest counter example I can think of would be Warren Buffett's USG which is helped execute a rights offering (similar to warrant dividend only a far more helpful idea than a worthless warrant that offers zero chance of help for 5 years). In that case there was no short squeeze and no, shorts weren't in trouble. The company did great later when the business turned around but not before. Shorts simply were short the rights offering as well just like they were short the stock.
My advice -- don't take my word for it or blindly listen to some other dude down 80% on his stock.
Three options:
1. Walk into a competent brokerage house with that plan printed out. Be prepared to hear them chuckle but they will be nice.
2. Do the same thing only with any college professor in the finance department.
3. Do some googling and see for yourself how this stuff works. See if exactly what I said it was happens every time or see if I'm wrong and there are counter examples. The closest counter example I can think of would be Warren Buffett's USG which is helped execute a rights offering (similar to warrant dividend only a far more helpful idea than a worthless warrant that offers zero chance of help for 5 years). In that case there was no short squeeze and no, shorts weren't in trouble. The company did great later when the business turned around but not before. Shorts simply were short the rights offering as well just like they were short the stock.
The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
